Systemic infections alter cortical transcriptionalsignatures in Alzheimer’s disease
Authors:
- Giulia PegoraroGPGiulia Pegoraro
- Lachlan F. MacBeanLMLachlan F. MacBean
- Adam R. SmithASAdam R. Smith
- Darren M. SoanesDSDarren M. Soanes
- Rebecca G. SmithRSRebecca G. Smith
- Jennifer ImmJIJennifer Imm
- Joshua HarveyJHJoshua Harvey
- Morteza KouhsarMKMorteza Kouhsar
- Valentin LarocheVLValentin Laroche
- Luke WeymouthLWLuke Weymouth
- Isabel CastanhoICIsabel Castanho
- Winston HideWHWinston Hide
Preprint
Abstract
Alzheimer’s disease (AD) is characterized by neuroinflammation, yet the impact of concurrent systemic infections on the AD brain remains poorly understood. We investigated the molecular mechanisms underlying the central nervous system response to systemic infections in AD by analyzing RNA sequencing data generated in the prefrontal cortex from 202 post-mortem donors (113 AD, 89 controls), where we stratified by the presence of a respiratory infection at the time of death. We identified 763 significantly differentially expressed genes (DEGs) between AD and controls without infection, which were enriched for oxidative phosphorylation and neurodegenerative pathways. In contrast, 122 DEGs distinguished AD from controls during infection, with 57 genes uniquely altered in AD in the presence of infection, including MAPK4 , VAV3 , and POU3F4 , implicating infection-dependent mechanisms of vascular and immune regulation. Pathway activity analysis revealed that infection in AD suppresses some immune and vascular pathways, while enhancing transcriptional and developmental programs. Weighted gene co-expression network analysis uncovered three key modules: one module strongly associated with AD, enriched for aging and signal transduction; one module linked to both AD and infection, highlighting cytoskeletal remodelling and host–pathogen interactions; and one module specific to infection, enriched in astrocytes, pericytes, and endothelial cells, implicating blood–brain barrier dysfunction. These findings suggest that systemic respiratory infections reshape transcriptional programs in the AD brain, dampening immune effector pathways and engaging vascular and host–pathogen processes in blood–brain-barrier–associated cell types. Our results highlight the complex interplay between systemic infection, neuroinflammation, and vascular responses in AD.Keywords
This publication has 52 references indexed in Scilit:
- Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in ADExperimental Gerontology, 2024
- Associations of VGF with Neuropathologies and Cognitive Health in Older AdultsAnnals of Neurology, 2023
- Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer’s DiseaseMolecular Neurobiology, 2021
- Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse ModelsCell Reports, 2020
- Does SARS-CoV-2 infection cause chronic neurological complications?GeroScience, 2020
- The blood-brain barrier in Alzheimer's diseaseNeurobiology of Disease, 2017
- Herpes virus in Alzheimer's disease: relation to progression of the diseaseNeurobiology of Aging, 2014
- Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading enzyme (IDE) proximal promoter and repress its transcription and activity: Implications for cellular Aβ metabolismBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infectionActa Neuropathologica, 2007
- Oxidative phosphorylation defects and Alzheimer's diseaseneurogenetics, 1997